LIVN
LivaNova PLC
NASDAQ · Healthcare · Medical - Devices · GB
$81.92
+0.89%Aug 5, 2026, 10:00 UTC
LivaNova PLC reported its second-quarter 2026 financial results, with revenue of $390.6 million, up 10.8% on a reported basis and 9.8% on a constant-currency basis year-over-year, and U.S. GAAP diluted EPS of $1.93.
Jun 11, 2026, 17:44 UTC
Jette Nygaard-Andersen was elected to the Board of Directors of LivaNova PLC after its Annual General Meeting on June 10.
Source: